The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 341 through 350 of 882 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Babu, Mohan | The University of Regina | Operating Grant | $50,000

CIHR Saskatchewan 2021

Pulmonary vascular disease in patients with Long COVID

Weatherald, Jason | The University of Calgary | Operating Grant | $292,092

CIHR Alberta 2021

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Côté, Marceline | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID‑19 vaccines

Brockman, Mark A | Simon Fraser University | Operating Grant | $495,000

CIHR British Columbia 2021

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Mukherjee, Manali | McMaster University | Operating Grant | $499,245

CIHR Ontario 2021

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study

Gill, Michael J | The University of Calgary | Operating Grant | $434,655

CIHR Alberta 2021

Developing the VACCINE (VACine Confidence and ImmuNization Education) Checklist to support COVID‑19 vaccine confidence and uptake among workers in long-term care

Heer, Carrie | Bruyère Research Institute | Operating Grant | $258,785

CIHR Ontario 2021

A Qualitative Exploration of Vaccine Uptake and Hesitancy Among People Experiencing Homelessness in Toronto

Hwang, Stephen W | Unity Health Toronto | Operating Grant | $100,258

CIHR Ontario 2021

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Network – Innovative therapeutic approaches for the 2019-novel coronavirus

Boivin, Guy | CHU de Québec | Operating Grant | $100,000

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Pulmonary vascular disease in patients with Long COVID

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID‑19 vaccines

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study

Developing the VACCINE (VACine Confidence and ImmuNization Education) Checklist to support COVID‑19 vaccine confidence and uptake among workers in long-term care

A Qualitative Exploration of Vaccine Uptake and Hesitancy Among People Experiencing Homelessness in Toronto

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

COVID-19 Variant Network – Innovative therapeutic approaches for the 2019-novel coronavirus